Literature DB >> 34963833

Noninvasive Measurements of Breast Cancer-Related Lymphedema.

Harvey N Mayrovitz1.   

Abstract

Breast cancer-related lymphedema (BCRL) presents as swelling in the arm, hand, trunk, or breast at varying times after completion of breast cancer treatment. Its reported incidence varies widely in part due to its dependence on the type and extent of the treatment, co-present pre-treatment risk factors, and the criteria used to define its presence. Central to this issue is the quantitative measures that are variously used to specify lymphedema thresholds for its detection and tracking over time and during treatment. The goal of this paper is to discuss these issues and the methods available for the non-invasive quantitative assessment of BCRL. Operational principles and advantages and limitations of the various methods and their clinical history of use and effectiveness are discussed.
Copyright © 2021, Mayrovitz et al.

Entities:  

Keywords:  breast cancer; edema measurement; impedance; limb volumes; measuring lymphedema; tissue dielectric constant; water displacement

Year:  2021        PMID: 34963833      PMCID: PMC8695693          DOI: 10.7759/cureus.19813

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  47 in total

1.  Multi-frequency bioelectrical impedance augments the diagnosis and management of lymphoedema in post-mastectomy patients.

Authors:  L C Ward; I H Bunce; B H Cornish; B R Mirolo; B J Thomas; L C Jones
Journal:  Eur J Clin Invest       Date:  1992-11       Impact factor: 4.686

2.  Compression Treatment of Breast Edema: A Randomized Controlled Pilot Study.

Authors:  Karin Johansson; Charlotta Jönsson; Thomas Björk-Eriksson
Journal:  Lymphat Res Biol       Date:  2019-06-24       Impact factor: 2.589

3.  Variational formulation of open-ended coaxial line in contact with layered biological medium.

Authors:  E Alanen; T Lahtinen; J Nuutinen
Journal:  IEEE Trans Biomed Eng       Date:  1998-10       Impact factor: 4.538

4.  Early diagnosis of lymphedema using multiple frequency bioimpedance.

Authors:  B H Cornish; M Chapman; C Hirst; B Mirolo; I H Bunce; L C Ward; B J Thomas
Journal:  Lymphology       Date:  2001-03       Impact factor: 1.286

5.  In vivo dielectric properties of human skin from 50 MHz to 2.0 GHz.

Authors:  J P Grant; R N Clarke; G T Symm; N M Spyrou
Journal:  Phys Med Biol       Date:  1988-05       Impact factor: 3.609

6.  The problem of post-breast cancer lymphedema: impact and measurement issues.

Authors:  Jane M Armer
Journal:  Cancer Invest       Date:  2005       Impact factor: 2.176

7.  Measuring peripheral oedema and bioimpedance.

Authors:  L C Ward; B H Cornish
Journal:  Lymphology       Date:  1995-03       Impact factor: 1.286

8.  Tissue Dielectric Constant and Water Displacement Method Can Detect Changes of Mild Breast Cancer-Related Arm Lymphedema.

Authors:  Katarina Karlsson; Karin Johansson; Lena Nilsson-Wikmar; Christina Brogårdh
Journal:  Lymphat Res Biol       Date:  2021-09-22       Impact factor: 2.589

9.  Tissue Dielectric Constant Measures in Women With and Without Clinical Trunk Lymphedema Following Breast Cancer Surgery: A 78-Week Longitudinal Study.

Authors:  Linda A Koehler; Harvey N Mayrovitz
Journal:  Phys Ther       Date:  2020-08-12

10.  L-Dex, arm volume, and symptom trajectories 24 months after breast cancer surgery.

Authors:  Sheila H Ridner; Chirag Shah; John Boyages; Louise Koelmeyer; Nicolas Ajkay; Sarah M DeSnyder; Sarah A McLaughlin; Mary S Dietrich
Journal:  Cancer Med       Date:  2020-06-01       Impact factor: 4.452

View more
  2 in total

Review 1.  The Breast Edema Enigma: Features, Diagnosis, Treatment, and Recommendations.

Authors:  Sarina S Gupta; Harvey N Mayrovitz
Journal:  Cureus       Date:  2022-04-03

2.  Bioelectrical impedance analysis for early screening of upper limb subclinical lymphedema: A case-control study.

Authors:  Linli Zhuang; Huaying Chen; Xuemei Zheng; Shaoyong Wu; Youhui Yu; Lu Lan; Liang Xu; Jumei Xu; Hongying Fan
Journal:  PLoS One       Date:  2022-09-19       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.